-
公开(公告)号:US20220204555A1
公开(公告)日:2022-06-30
申请号:US17607747
申请日:2020-05-11
Applicant: CYTIVA BIOPROCESS R&D AB
Inventor: Martin HALL , Mats ANDER , Mikael BERG , Sandeep KRISTIANSSON
IPC: C07K1/22 , C07K14/755
Abstract: The present invention relates to a method for purification of plasma proteins. More closely, the invention relates to a method using magnetic beads for separation of different plasma proteins from a plasma fraction, such as a cryoprecipitate or cryosupernatant of plasma, or alternatively directly from cell culture of recombinant plasma proteins.
-
公开(公告)号:US20220106462A1
公开(公告)日:2022-04-07
申请号:US17550830
申请日:2021-12-14
Applicant: Cytiva BioProcess R&D AB
Inventor: Per Erik Emilsson , Susanna Klara Margareta Lindberg , Jonny Wernersson , Jonas Gustafsson , Adam Hurynowicz
Abstract: The invention discloses a method of manufacturing polysaccharide beads, comprising the steps of: i) providing a water phase comprising an aqueous solution of a polysaccharide; ii) providing an oil phase comprising at least one water-immiscible organic solvent and at least one oil-soluble emulsifier; iii) emulsifying the water phase in the oil phase to form a water-in-oil (w/o) emulsion; and iv) inducing solidification of the water phase in the w/o emulsion, wherein the organic solvent is an aliphatic or alicyclic ketone or ether.
-
公开(公告)号:US11285460B2
公开(公告)日:2022-03-29
申请号:US15120845
申请日:2015-02-18
Applicant: Cytiva BioProcess R&D AB
Inventor: Jean-Luc Maloisel , Karolina Busson , Karol Lacki , Bjorn Noren , Helena Skoglar
IPC: B01D15/12 , B01D15/20 , B01D15/30 , B01D15/36 , B01J20/28 , B01J20/286 , B01J20/32 , C07K1/22 , C07K14/765 , C07K14/77 , C12N1/20
Abstract: The invention discloses a separation matrix for purification of biological particles, comprising a plurality of particles having a porous core entity and a porous shell entity covering the core entity, wherein the core entity comprises at least 50 micromole/ml primary amines present on covalently attached ligands displaying at least two primary amines per ligand and the shell entity comprises less than 20 micromole/ml primary amines The invention further discloses a method of purifying biological particles and a method of manufacturing a separation matrix.
-
公开(公告)号:US20220016547A1
公开(公告)日:2022-01-20
申请号:US17488046
申请日:2021-09-28
Applicant: Cytiva BioProcess R&D AB
Inventor: Klaus Gebauer
Abstract: A separation system may include a number of parallel fluid paths. Each parallel fluid path may include a separation module, and an adjustable flow restrictor. Each adjustable flow restrictor is operable sequentially and operable such that the hydraulic resistance of all the parallel fluid paths is substantially the same and is equal to or higher than the hydraulic resistance of a fluid path identified to have the highest hydraulic resistance. The system includes a pressure sensor that measures pressure loss over the whole separation system. The system is operable such that the hydraulic resistances of the respective separation modules are synchronised, and such that when operated in parallel and at substantially the same time, the respective modules have substantially the same time residence times. The system may include a control system for automated operation.
-
公开(公告)号:US20210187476A1
公开(公告)日:2021-06-24
申请号:US17252378
申请日:2019-06-25
Applicant: Cytiva BioProcess R&D AB
Inventor: Johan Fredrik Öhman , Jesper Ulf Hansson , Jasmin Faroque , Eva Holmgren , David Bror Lennart Jansson
IPC: B01J20/24 , B01J20/28 , B01J20/288 , B01J20/30 , B01J20/32 , C08B37/00 , B01J20/281
Abstract: The present invention relates to chromatography beads, production and use thereof. More closely the invention relates to small, rigid and nan-permeable agarose beads suitable for example as stationary phase in high performance liquid chromatography (HPLC) for analyses of biomolecules, such as, peptides and proteins; and methods for producing such beads.
-
公开(公告)号:US20210162319A1
公开(公告)日:2021-06-03
申请号:US17153015
申请日:2021-01-20
Applicant: CYTIVA BIOPROCESS R&D AB
Inventor: Sophia Hober
IPC: B01D15/38 , B01J20/286 , B01J20/32 , C07K1/22 , C07K16/06 , C07K14/31 , C07K14/195 , B01J20/24 , B01J20/289 , C07K14/00
Abstract: The present invention relates to an immunoglobulin-binding protein, wherein at least one asparagine residue has been mutated to an amino acid other than glutamine or aspartic acid, which mutation confers an increased chemical stability at pH-values of up to about 13-14 compared to the parental molecule. The protein can for example be derived from a protein capable of binding to other regions of the immunoglobulin molecule than the complementarity determining regions (CDR), such as protein A, and preferably the B-domain of Staphylococcal protein A. The invention also relates to a matrix for affinity separation, which comprises an immunoglobulin-binding protein as ligand coupled to a solid support, in which protein ligand at least one asparagine residue has been mutated to an amino acid other than glutamine.
-
公开(公告)号:US20210087227A1
公开(公告)日:2021-03-25
申请号:US17114773
申请日:2020-12-08
Applicant: CYTIVA BIOPROCESS R&D AB
Inventor: Gustav José Rodrigo , Tomas Bjorkman , Mats Ander
IPC: C07K1/22 , B01J20/26 , B01J20/285 , B01J20/286 , B01J20/32 , C07K14/31 , C07K16/00 , C07K16/12 , C07K17/10 , B01D15/38 , B01J20/24 , B01J20/28 , C07K16/06
Abstract: An Fc-binding polypeptide of improved alkali stability, comprising a mutant of a parental Fc-binding domain of Staphylococcus Protein A (SpA), as defined by SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO:3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:22, SEQ ID NO: 51 or SEQ ID NO: 52, wherein at least the asparagine or serine residue at the position corresponding to position 11 in SEQ ID NO:4-7 has been mutated to an amino acid selected from the group consisting of glutamic acid, lysine, tyrosine, threonine, phenylalanine, leucine, isoleucine, tryptophan, methionine, valine, alanine, histidine and arginine.
-
公开(公告)号:US20210060525A1
公开(公告)日:2021-03-04
申请号:US17045779
申请日:2019-04-24
Applicant: Cytiva BioProcess R&D AB
Inventor: Jonas Bengtsson , Linn Carlsson , Andreas Axen , Ronnie Palmgren
IPC: B01J20/24 , B01J20/28 , B01J20/291 , B01J20/30 , B01J20/281 , B01D15/08
Abstract: The invention discloses a separation matrix comprising polysaccharide gel beads, wherein said polysaccharide gel beads comprise embedded fibers. The invention further discloses a method of preparing the separation matrix and use of the matrix for separation purposes.
-
公开(公告)号:US20210057049A1
公开(公告)日:2021-02-25
申请号:US17045775
申请日:2019-04-24
Applicant: Cytiva BioProcess R&D AB
Inventor: Gunnar Malmquist , Per Liden
Abstract: The present invention relates to a method for estimating performance of a bioprocess material when used in a bioprocess system. The bioprocess material comprising at least two ingredients, each having data properties. The method comprises: i) obtaining (81) the data properties for the at least two ingredients used to produce the bioprocess material; ii) defining (82) procedures to process the at least two ingredients; iii) processing (83) the at least two ingredients according to the defined process parameters to obtain at least a product; iv) measuring (84) data properties of each product, v) calculating (85) data properties of each product based on the measured data properties of each product and/obtain or data properties from the at least two ingredients, and vi)if the product is the bioprocess material, processing (88) the measured and calculated data properties to estimate the impact of the bioprocess material on a target product in the bioprocess system, or vii) if the product is not the bioprocess material, treating the product as an intermediate material and repeating (87) steps iii)-vi) with each product as one of the at least two ingredients.
-
公开(公告)号:US10889615B2
公开(公告)日:2021-01-12
申请号:US16096869
申请日:2017-05-10
Applicant: Cytiva BioProcess R&D AB
Inventor: Gustav José Rodrigo , Tomas Bjorkman , Mats Ander
IPC: C07K1/22 , B01J20/26 , C07K14/31 , C07K16/00 , B01J20/32 , B01J20/285 , B01J20/286 , C07K16/12 , C07K17/10
Abstract: An Fc-binding polypeptide of improved alkali stability, comprising a mutant of a parental Fc-binding domain of Staphylococcus Protein A (SpA), as defined by SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO:3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:22, SEQ ID NO 51 or SEQ ID NO 52, wherein at least the asparagine or serine residue at the position corresponding to position 11 in SEQ ID NO: 4-7 has been mutated to an amino acid selected from the group consisting of glutamic acid, lysine, tyrosine, threonine, phenylalanine, leucine, isoleucine, tryptophan, methionine, valine, alanine, histidine and arginine.
-
-
-
-
-
-
-
-
-